ARCHIVES

Marijuana-Derived Drug Less Effective Than Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 3 | March 29, 2002

Download PDF Visit The Full Archive

Related Articles

ASCO Honors Community Practices For Trial Participation.

June 1, 2007

NCAB Action On Diet FIT “Not Cavalier,” Chairman Korn Says

November 10, 1989

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

April 26, 2013

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

April 30, 2004

Fitness Reduces Risk of Death From Lung, Colorectal, Prostate Cancer in Middle-Aged Men

May 31, 2013

Comprehensive Center NCAB Evaluations

June 2, 1978